Medtide Inc.
Status: Publicly traded
Direct answer
Medtide Inc. is publicly traded on HKSE under the ticker 3880.HK.
Medtide Inc. operates as a contract research, development, and manufacturing organization (CRDMO), providing comprehensive services across the entire pharmaceutical lifecycle, from initial drug discovery and preclinical investigation through to clinical development and commercial-scale production. The company specializes in the synthesis of novel peptide chemical entities for discovery purposes, along with the...
Can you invest in Medtide Inc.?
Yes. Medtide Inc. is publicly traded on HKSE under the ticker 3880.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Medtide Inc.
Detailed equity research is provided by MarketSnap.